AllianceBernstein
IMCR icon

AllianceBernstein’s Immunocore IMCR Stock Holding History

AllianceBernstein’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-97,381
Closed -$6.33M – 3266
2024
Q1 		$6.33M Buy
97,381
+23,970
+33% +$1.64M ﹤0.01% 1382
2023
Q4 		$5.02M Sell
73,411
-47,183
-39% -$2.45M ﹤0.01% 1493
2023
Q3 		$6.26M Buy
120,594
+70,238
+139% +$4.16M ﹤0.01% 1325
2023
Q2 		$3.02M Buy
+50,356
New +$2.87M ﹤0.01% 1674

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AllianceBernstein's IMCR Position: Q2 2024 in Review

AllianceBernstein sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 97,381 shares — an estimated $6.33M sold.

AllianceBernstein first reported a position in IMCR in Q2 2023 and held it in 4 quarters. The position peaked at $6.33M in Q1 2024. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • AllianceBernstein reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 97,381 Immunocore shares in Q2 2024, an estimated $6.33M.
  • AllianceBernstein first reported a position in Immunocore in Q2 2023 and held it in 4 quarters.
  • AllianceBernstein's Immunocore position peaked at $6.33M in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.